Skip to content

ACURA PHARMACEUTICALS, INC.

CIK 0000786947

← back to feed
Revenue (TTM)
$1.94M
−56.2% YoY FY Apr 2023
Net Income (TTM)
−$1.59M
+27.2% YoY FY Apr 2023
EPS Diluted (TTM)
−$0.04
+50.0% YoY FY Apr 2023
Gross Margin
—
FY Apr 2023
Operating Margin
-79.6%
FY Apr 2023
Net Margin
-81.9%
FY Apr 2023
Free Cash Flow (TTM)
−$1.46M
FY Apr 2023
Cash
$95K
FY Apr 2023
Total Debt
$6M
FY Apr 2023
Shares Outstanding
66M sh
FY Apr 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings